Daniel M. Junius, Director at GLYCOMIMETICS INC (GLYC), bought 30,000 shares at $1.56 ($47K) on 2023-05-10, disclosed to the SEC on 2023-05-11.
Open-market purchase of $47k GLYC by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| IDXX | SELL | 2022-12-07 | $2.6M | — | Filing → |
| GLYC | BUY | 2022-11-18 | $37K | — | Filing → |
| IDXX | SELL | 2021-08-12 | $3.3M | — | Filing → |